Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "Sepsis Diagnostics Market 2025-2029 - Global Market Forecasts by Assay, Cause, Product, Lab and Place, with Executive and Consultant Guides" has been added to ResearchAndMarkets.com's offering.
With over 45 million people affected annually, sepsis remains a critical global health challenge, yet lacks a definitive diagnostic. The integration of genomic and molecular diagnostic tools over the past decade has accelerated the race for an effective solution.
Artificial Intelligence could potentially play a pivotal role in this innovation landscape. While it's uncertain which entities will emerge victorious, the stakes are undeniably high, with emergency life-saving diagnostics capable of commanding premium market prices. Understanding the diverse drivers within this expansive global diagnostic market helps identify lucrative opportunities.
Our comprehensive insights form the foundation of your success. The report projects the market's growth over the next five years, driven by fundamental health care improvements worldwide. The pandemic's legacy has reshaped the landscape, particularly for respiratory infections. Current key players have already made significant advances, yet disruptive diagnostic technologies could redefine the field. Explore this dynamic market, including its challenges and prospects, with emerging trends in Rapid Diagnostics and the Genomics Revolution converging to forge novel diagnostic possibilities.
Position yourself as a leading expert in your organization by leveraging our in-depth research. We offer assistance and additional specialized data at no extra cost. Make informed investment decisions and conduct confident valuations using the most up-to-date information available.
Key Topics Covered:
1 Market Guides
1.1 Situation Analysis
1.2 Guide for Executives and Marketing Staff
1.3 Guide for Investment Analysts and Management Consultants
2 Introduction and Market Definition
2.1 An Overview of Sepsis Diagnostics
2.2 Market Definition
2.3 Methodology
2.4 Perspective: Healthcare and the IVD Industry
3 Sepsis - Current Science
3.1 What is Sepsis?
3.2 Diagnosis
3.3 Causes of Sepsis
3.4 Prevalence
4 Industry Overview
4.1 Players in a Dynamic Market
5 Market Trends
5.1 Factors Driving Growth
5.2 Factors Limiting Growth
5.3 Instrumentation, Automation and Diagnostic Trends
6 Sepsis Diagnostics - Recent Developments
6.1 Recent Developments - Importance and How to Use This Section
6.2 FDA Clears Abionic's Sepsis Test
6.3 MicrosensDx to develop sepsis test
6.4 Cytovale's sepsis diagnostic test shows results
6.5 Inflammatix Completes Sepsis Test System
6.6 Microplate Dx to Launch UTI Susceptibility Test
[... additional entries truncated for brevity ...]
7 Profiles of Key Companies
7.1 Abbott Laboratories
7.2 Abionic
7.3 Accel Diagnostics
[... additional entries truncated for brevity ...]
8 Sepsis Global Diagnostic Markets Overview
8.1 Sepsis Diagnostics - Global Market Overview by Country
8.2 Global Sepsis Diagnostics Markets Overview by Assay
8.3 Global Sepsis Diagnostics Markets Overview by Cause
8.4 Global Sepsis Diagnostics Markets Overview by Product
8.5 Global Sepsis Diagnostics Markets Overview by Lab
8.6 Global Sepsis Diagnostics Markets Overview by Place
9 Sepsis Diagnostic Market - by Assay
9.1 Sepsis Diagnostic - Microbiology
9.2 Sepsis Diagnostic - PCR
9.3 Sepsis Diagnostic - Immunoassay
9.4 Sepsis Diagnostic - Infectious Disease Other
9.5 Sepsis Diagnostic - Biomarker MDx
9.6 Sepsis Diagnostic - Biomarker Other
10 Global Sepsis Diagnostics Markets - By Cause
10.1 Sepsis Diagnostic - GastroIntestinal
10.2 Sepsis Diagnostic - Respiratory COVID-19
10.3 Sepsis Diagnostic - Respiratory Other
10.4 Sepsis Diagnostic - Neonatal
10.5 Sepsis Diagnostic - Other Cause
11 Global Sepsis Diagnostics Markets - By Product
11.1 Sepsis Diagnostic - Instrumentation
11.2 Sepsis Diagnostic - Consumables
11.3 Sepsis Diagnostic - Software & Service
12 Global Sepsis Diagnostics Markets - By Lab
12.1 Sepsis Diagnostic - In Lab
12.2 Sepsis Diagnostic - Point of Care
13 Global Sepsis Diagnostics Markets - By Place
13.1 Sepsis Diagnostic - Hospital
13.2 Sepsis Diagnostic - Other Place
14 Appendices
14.1 United States Medicare System: Clinical Laboratory Fees Schedule
14.2 The Most Used IVD Assays
14.3 The Highest Grossing Assay
Companies Featured
- Abbott Laboratories
- Abionic
- Accel Diagnostics
- Accelerate Diagnostics
- ADT Biotech
- Anatolia Geneworks
- Axis-Shield Diagnostics Ltd.
- Baebies
- Beckman Coulter Diagnostics
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Biocartis
- BioFire Diagnostics (bioMerieux)
- bioMerieux Diagnostics
- Bruker
- Cube Dx
- Curetis N.V. / Curetis GmbH
- Cytovale
- Deepull Diagnostics
- DNAe
- EKF Diagnostics Holdings
- GeneFluidics
- GenMark Dx (Roche)
- Grifols
- Immunexpress
- Inflammatix
- LightDeck Diagnostics
- Linear Diagnostics
- Luminex Corp (DiaSorin)
- Mobidiag (Hologic)
- NanoDx
- Nanomix
- Qiagen
- Response Biomedical
- Roche Molecular Diagnostics
- SeLux Diagnostics
- Septec
- Siemens Healthineers
- Sphingotec
- T2 Biosystems
- Thermo Fisher Scientific Inc.
- Vela Diagnostics
For more information about this report visit https://www.researchandmarkets.com/r/jdvw8l
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
